TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BNTX

BioNTech SE

Healthcare · Biotechnology

98.50$ -0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

BioNTech SE (BNTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 438 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Cash Flow BNTX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-53 -58 -199 -14 890 13,577 5,371 208 438
11 22 34 39 75 123 183 298 368
5.9 7.6 30 32 94 109 51 101 106
31 8.2 30 26 1,252 – – – –
-8.0 -41 -84 -93 -10,730 4,519 5,575 1,221 517
58 68 71 85 154 363 706 452 168
-53 -67 -77 -145 -566 -35 -6,955 -2,081 -2,371
0.0 0.0 0.0 0.0 0.0 484 0.0 0.0 –
0.0 362 375 0.0 0.0 -986 -739 0.0 0.0
-1.6 3.5 7.9 142 -67 -59 -40 -46 -51
-1.6 365 383 895 94 -1,419 -779 -46 -51
-132 239 108 691 483 12,182 -2,211 -1,902 -931
-110 -126 -270 -99 736 13,214 4,666 -245 270

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?